Cargando…

Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study

BACKGROUND: Prospective research of children receiving heterogeneous vaccines has shown that immunization is not associated with pediatric idiopathic nephrotic syndrome (NS) relapses. However, prospective data concentrating only on influenza (flu) virus vaccines are not available. METHODS: This mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishimori, Shingo, Horinouchi, Tomoko, Fujimura, Junya, Yamamura, Tomohiko, Matsunoshita, Natsuki, Kamiyoshi, Naohiro, Sato, Mai, Ogura, Masao, Kamei, Koichi, Ishikura, Kenji, Iijima, Kazumoto, Nozu, Kandai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709736/
https://www.ncbi.nlm.nih.gov/pubmed/36449102
http://dx.doi.org/10.1007/s00467-022-05783-z
_version_ 1784841222340214784
author Ishimori, Shingo
Horinouchi, Tomoko
Fujimura, Junya
Yamamura, Tomohiko
Matsunoshita, Natsuki
Kamiyoshi, Naohiro
Sato, Mai
Ogura, Masao
Kamei, Koichi
Ishikura, Kenji
Iijima, Kazumoto
Nozu, Kandai
author_facet Ishimori, Shingo
Horinouchi, Tomoko
Fujimura, Junya
Yamamura, Tomohiko
Matsunoshita, Natsuki
Kamiyoshi, Naohiro
Sato, Mai
Ogura, Masao
Kamei, Koichi
Ishikura, Kenji
Iijima, Kazumoto
Nozu, Kandai
author_sort Ishimori, Shingo
collection PubMed
description BACKGROUND: Prospective research of children receiving heterogeneous vaccines has shown that immunization is not associated with pediatric idiopathic nephrotic syndrome (NS) relapses. However, prospective data concentrating only on influenza (flu) virus vaccines are not available. METHODS: This multicenter prospective study was conducted in children with NS who received inactivated flu vaccines from June 2017 to July 2018. The day of flu vaccination was defined as day 0, and the period between prevaccination and postvaccination days was defined as − X to + Y (period from day − 180 to 0 as the precontrolled period). The primary outcome was the NS relapse rate from day 0 to + 30 as a direct association with vaccination compared with those in the precontrolled period. Exacerbation was defined as children experiencing more NS relapses after vaccination compared with those in the precontrolled period, or children starting any new immunosuppressants due to NS relapse after vaccination. RESULTS: Sixty-three children were included. Relapse rates were not significantly different between the precontrolled period and 0 to + 30 periods (0.38 vs. 0.19 times/person-year, p = 0.95). Although the exacerbation rate during the 0 to + 180 period in children without NS relapse in the precontrolled period was very low (4/54 [7.4 %]), children with at least one NS relapse in the precontrolled period showed a remarkable increase in the rate (4/9 [44.4%]; p = 0.01). CONCLUSIONS: Flu vaccination did not significantly precipitate the direct relapse of NS in children. However, it might increase the disease activity in children with at least one NS relapse within a half year before vaccination. GRAPHICAL ABSTRACT: [Figure: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-022-05783-z.
format Online
Article
Text
id pubmed-9709736
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-97097362022-11-30 Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study Ishimori, Shingo Horinouchi, Tomoko Fujimura, Junya Yamamura, Tomohiko Matsunoshita, Natsuki Kamiyoshi, Naohiro Sato, Mai Ogura, Masao Kamei, Koichi Ishikura, Kenji Iijima, Kazumoto Nozu, Kandai Pediatr Nephrol Original Article BACKGROUND: Prospective research of children receiving heterogeneous vaccines has shown that immunization is not associated with pediatric idiopathic nephrotic syndrome (NS) relapses. However, prospective data concentrating only on influenza (flu) virus vaccines are not available. METHODS: This multicenter prospective study was conducted in children with NS who received inactivated flu vaccines from June 2017 to July 2018. The day of flu vaccination was defined as day 0, and the period between prevaccination and postvaccination days was defined as − X to + Y (period from day − 180 to 0 as the precontrolled period). The primary outcome was the NS relapse rate from day 0 to + 30 as a direct association with vaccination compared with those in the precontrolled period. Exacerbation was defined as children experiencing more NS relapses after vaccination compared with those in the precontrolled period, or children starting any new immunosuppressants due to NS relapse after vaccination. RESULTS: Sixty-three children were included. Relapse rates were not significantly different between the precontrolled period and 0 to + 30 periods (0.38 vs. 0.19 times/person-year, p = 0.95). Although the exacerbation rate during the 0 to + 180 period in children without NS relapse in the precontrolled period was very low (4/54 [7.4 %]), children with at least one NS relapse in the precontrolled period showed a remarkable increase in the rate (4/9 [44.4%]; p = 0.01). CONCLUSIONS: Flu vaccination did not significantly precipitate the direct relapse of NS in children. However, it might increase the disease activity in children with at least one NS relapse within a half year before vaccination. GRAPHICAL ABSTRACT: [Figure: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-022-05783-z. Springer Berlin Heidelberg 2022-11-30 2023 /pmc/articles/PMC9709736/ /pubmed/36449102 http://dx.doi.org/10.1007/s00467-022-05783-z Text en © The Author(s), under exclusive licence to International Pediatric Nephrology Association 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Ishimori, Shingo
Horinouchi, Tomoko
Fujimura, Junya
Yamamura, Tomohiko
Matsunoshita, Natsuki
Kamiyoshi, Naohiro
Sato, Mai
Ogura, Masao
Kamei, Koichi
Ishikura, Kenji
Iijima, Kazumoto
Nozu, Kandai
Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
title Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
title_full Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
title_fullStr Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
title_full_unstemmed Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
title_short Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
title_sort is influenza vaccination associated with nephrotic syndrome relapse in children? a multicenter prospective study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709736/
https://www.ncbi.nlm.nih.gov/pubmed/36449102
http://dx.doi.org/10.1007/s00467-022-05783-z
work_keys_str_mv AT ishimorishingo isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT horinouchitomoko isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT fujimurajunya isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT yamamuratomohiko isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT matsunoshitanatsuki isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT kamiyoshinaohiro isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT satomai isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT oguramasao isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT kameikoichi isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT ishikurakenji isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT iijimakazumoto isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy
AT nozukandai isinfluenzavaccinationassociatedwithnephroticsyndromerelapseinchildrenamulticenterprospectivestudy